Intravascular large B-cell lymphoma with reversible central hypopituitarism.

BMJ Case RepSep 7, 2026 (epub)

Ryuichiro Yamasaki, Masaru Shibata, Kimihisa Awata et al.

✦ AI-curated · Sources linked

Case in brief

A woman in her late 60s presented with fever and general fatigue. Investigations showed bicytopenia, splenomegaly, and central hypothyroidism. Brain MRI indicated enlargement of the anterior pituitary lobe. A skin biopsy revealed atypical lymphocytes in small vessels, confirming intravascular large B-cell lymphoma. The patient achieved complete remission after chemotherapy and stem cell transplantation, with restored endocrine function.

What made this case unusual

This case highlights a rare presentation of intravascular large B-cell lymphoma with hypopituitarism, which is not commonly associated with this type of lymphoma.

Diagnostic / clinical pearl

Clinicians should consider intravascular large B-cell lymphoma in patients presenting with unexplained hypopituitarism and atypical lymphocyte findings.

Why it matters

Recognizing this association can lead to timely diagnosis and treatment, potentially improving patient outcomes in similar cases.

Source

Published in BMJ Case Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.